The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Flushing out the weak!!ha ha the weak are the ones that have watched all there money dissappear on a daily basis!!
There are so many on here doing the exact opposite if what they should be doing!!
Even if gdr get a contract its going to be miniscule. Investors here may like the product but it carn sell!!
One of the thunhs that really put me of was the fake european 10 million contract that nevver happened and was brushed under the carpet
Meeja
It was unrealistic at 80p aswell, sp can overshoot in both directions.
20p would be a good buy in ,but even then it could overshoot back to 17p.
Everone here has different criteria as to there calcuated risk. If your strategy is working keep at it.if its not then you need to change your strategy.
Id rather make 15%a year over my portfolio then be 50+% down!
Below is from the bottom of 22nd december rns
Potential commercial partners, testing suppliers, or clinical professionals interested in the new Genedrive® COV19-ID Kit can contact the Company via info@genedrive.com. Information about the new Genedrive®?COV19-ID Kit can be found at https://www.genedrive.com/assays/cov19-id-assay.php
Potential customers are asked to get in touch!! Go out and find the customers!!
I honestly think they have nothing lined up.and judging by the sp the market thinks the same.